New framework developed for treating liver cancer by UT Southwestern-led research could lead to updated standards

DELFI liquid biopsy detects liver cancer across diverse international populations, Hopkins-led study finds

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

August 07, 2026

Vol.52 No.31

Clinical Roundup

UTSW study shows how RNA-modifying enzyme linked to cancer picks its targets

An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers.

July 02, 2026

Vol.52 No.26

Clinical Roundup

Antibody may improve treatment response in lung cancer, UTSW-led study finds

An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumors in preclinical models of non-small cell lung cancer, even those resistant to a targeted therapy, a study led by UT Southwestern Medical Center researchers showed. This discovery could eventually lead to a new class of drugs to treat NSCLC and potentially other cancers.

June 18, 2026

Vol.52 No.24

In Brief

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Jason Chiang and Kyung Sung of the Department of Radiological Sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3.2 million, five-year grant from NCI to develop an artificial intelligence-enhanced imaging platform designed to improve yttrium-90 (Y90) radioembolization planning for patients with liver cancer.

June 05, 2026

Vol.52 No.22

Clinical Roundup

Ovarian cancer cells use stress hormone signaling to shut down immune system, UTSW study finds

When activated in ovarian cancer cells, the receptor for the body’s primary stress hormone alters the tumor environment in ways that blunt immune response, according to research led by UT Southwestern Medical Center.

May 29, 2026

Vol.52 No.21

Clinical Roundup

UTSW researchers identify central signaling pathway that enables survival without the need for genetic change

UT Southwestern Medical Center researchers have discovered a key molecular mechanism that allows animals to adapt to changing environmental conditions without altering their genes—an ability known as phenotypic plasticity.

May 22, 2026

Vol.52 No.20

New framework developed for treating liver cancer by UT Southwestern-led research could lead to updated standards

YOU MAY BE INTERESTED IN

DELFI liquid biopsy detects liver cancer across diverse international populations, Hopkins-led study finds

UTSW study shows how RNA-modifying enzyme linked to cancer picks its targets

Antibody may improve treatment response in lung cancer, UTSW-led study finds

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Ovarian cancer cells use stress hormone signaling to shut down immune system, UTSW study finds

UTSW researchers identify central signaling pathway that enables survival without the need for genetic change

Renew today!

Subscriber content

Never miss an issue!

Login